Nature

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy

The development of novel therapeutic strategies is imperative for the treatment of advanced cancers like ovarian cancer and glioma, which are resistant to most traditional treatment modalities. In ...
Nature

Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways

In this study, we have applied high-density oligonucleotide microarray technology to characterize biologic changes associated with adenoviral vector-mediated target cell infection. We infected a human ...
Yahoo Finance

Adeno-associated Virus Gene Therapy Market Report 2024-2034: Epidemiology, Industry Trends and Forecasts

Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Adeno-associated Virus Gene Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been ...
Yahoo Finance

Coave Therapeutics Showcases Breakthrough in Peptide-Based Conjugated AAV Vectors Using ALIGATER™ Platform in a Late-Breaking Abstract at ESGCT 2024

Paris, France, October 22, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company developing novel delivery vectors for the treatment of eye and neurodegenerative diseases, today announced ...
News Medical

Retinal organoids and RPE models for retinal gene therapy development

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
PharmTech

Taking Stock of a Maturing CGT Sector

As the CGT market matures, increased focus lays in securing optimal efficacy while ensuring safety. Advances in development and manufacturing of cell and gene therapies (CGTs) have been focusing on ...